Literature DB >> 9533606

The time course of post-lumbar puncture headache.

S T Vilming1, R Kloster.   

Abstract

According to the leakage theory, the time taken for pain to develop upon rising to the upright position will increase during the time course of post-lumbar puncture headache (PPH) as a consequence of the decreasing size of the healing dural rent, and the pain will decline. The aim of the present prospective study was to test this hypothesis, and to describe the temporal course of time and pain variables in PPH. The study showed that the course was fairly stable for all variables except on the first day, the second last day, and the last day. In the recumbent position, the headache was more severe on the first day (p<0.05) and milder on the last day (p<0.001) compared with the interim days; maximal headache in the upright position was milder on the second last (p<0.005) and last days (p<0.0001). Compared with the interim days, the time prior to increase of pain upon rising was shorter on the first day (p<0.05) and longer on the last day (p<0.001), and from start of increase until maximum was longer on the last day (p<0.01). The time to pain relief upon lying down did not vary significantly throughout the PPH period. The mobility of the patient as expressed by the PPH grade was fairly stable throughout the course of PPH until it increased in the last 2 days. The results are in good accord with the leakage theory.

Entities:  

Mesh:

Year:  1998        PMID: 9533606     DOI: 10.1046/j.1468-2982.1998.1802097.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  1 in total

1.  Randomized phase I clinical trial of anti-α-synuclein antibody BIIB054.

Authors:  Miroslaw Brys; Laura Fanning; Serena Hung; Aaron Ellenbogen; Natalia Penner; Minhua Yang; Mackenzie Welch; Erica Koenig; Eric David; Tara Fox; Shavy Makh; Jason Aldred; Ira Goodman; Blake Pepinsky; YuTing Liu; Danielle Graham; Andreas Weihofen; Jesse M Cedarbaum
Journal:  Mov Disord       Date:  2019-06-17       Impact factor: 10.338

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.